effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial

• Published in: Nutrition & metabolism 2014-08, Vol.11 (1), p.39-39, Article 39
• Main Authors: Soare, Andreea, Khazrai, Yeganeh M, Del Toro, Rossella, Roncella, Elena, Fontana, Lucia, Fallucca, Sara, Angeletti, Silvia, Formisano, Valeria, Capata, Francesca, Ruiz, Vladimir, Porrata, Carmen, Skrami, Edlira, Gesuita, Rosaria, Manfrini, Silvia, Fallucca, Francesco, Pianesi, Mario, Pozzilli, Paolo
• Format: Article
• Language: English
• Subjects: blood glucose; Blood pressure; body mass index; body weight; Carbohydrates; Cardiovascular disease; Cholesterol; Clinical trials; College campuses; Confidence intervals; Diabetes; Diet; Diet therapy; Exercise; fasting; Food; gender; Grain; Health aspects; high density lipoprotein; Hotels & motels; Insulin resistance; Intervention; Legumes; Lipoproteins; low density lipoprotein cholesterol; noninsulin-dependent diabetes mellitus; Nutrition research; Patients; physical activity; professional societies; Studies; triacylglycerols; Type 2 diabetes; waist; Writing
• ISSN: 1743-7075; 1743-7075
• DOI: 10.1186/1743-7075-11-39

BACKGROUND: Diet is an important component of type 2 diabetes therapy. Low adherence to current therapeutic diets points out to the need for alternative dietary approaches. This study evaluated the effect of a different dietary approach, the macrobiotic Ma-Pi 2 diet, and compared it with standard diets recommended for patients with type 2 diabetes. METHODS: A randomized, controlled, open-label, 21-day trial was undertaken in patients with type 2 diabetes comparing the Ma-Pi 2 diet with standard (control) diet recommended by professional societies for treatment of type 2 diabetes. Changes in fasting blood glucose (FBG) and post-prandial blood glucose (PPBG) were primary outcomes. HbA₁c, insulin resistance (IR), lipid panel and anthropometrics were secondary outcomes. RESULTS: After correcting for age, gender, BMI at baseline, and physical activity, there was a significantly greater reduction in the primary outcomes FBG (95% CI: 1.79; 13.46) and PPBG (95% CI: 5.39; 31.44) in those patients receiving the Ma-Pi 2 diet compared with those receiving the control diet. Statistically significantly greater reductions in the secondary outcomes, HbA₁c (95% CI: 1.28; 5.46), insulin resistance, total cholesterol, LDL cholesterol and LDL/HDL ratio, BMI, body weight, waist and hip circumference were also found in the Ma-Pi 2 diet group compared with the control diet group. The latter group had a significantly greater reduction of triglycerides compared with the Ma-Pi 2 diet group. CONCLUSIONS: Intervention with a short-term Ma-Pi 2 diet resulted in significantly greater improvements in metabolic control in patients with type 2 diabetes compared with intervention with standard diets recommended for these patients. TRIAL REGISTRATION: Current Controlled Trials ISRCTN10467793 .